相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single-Dose, Placebo-Controlled, Randomized Study of AMG 785, a Sclerostin Monoclonal Antibody
Desmond Padhi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Regulation of Circulating Sclerostin Levels by Sex Steroids in Women and in Men
Ulrike Il Moedder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Sclerostin and the Regulation of Bone Formation: Effects in Hip Osteoarthritis and Femoral Neck Fracture
Jon Power et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Inhibition of Sclerostin by Monoclonal Antibody Increases Bone Formation, Bone Mass, and Bone Strength in Aged Male Rats
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women
Matthew T. Drake et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss
Agostino Gaudio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Localization of SOST/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro
A. Jaeger et al.
JOURNAL OF PERIODONTAL RESEARCH (2010)
Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by γ-carboxylation-dependent and -independent mechanisms
Gerald J. Atkins et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles
Gerald J. Atkins et al.
BIOMATERIALS (2009)
Pro-Inflammatory Cytokines TNF-Related Weak Inducer of Apoptosis (TWEAK) and TNFα Induce the Mitogen-Activated Protein Kinase (MAPK)-Dependent Expression of Sclerostin in Human Osteoblasts
Cristina Vincent et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Sclerostin in Mineralized Matrices and van Buchem Disease
R. L. van Bezooijen et al.
JOURNAL OF DENTAL RESEARCH (2009)
Novel Regulators of Fgf23 Expression and Mineralization in Hyp Bone
Shiguang Liu et al.
MOLECULAR ENDOCRINOLOGY (2009)
Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response
G. J. Atkins et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
Hong Y. Choi et al.
PLOS ONE (2009)
Degradation of MEPE, DMP1, and release of SIBLING ASARM-Peptides (Minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP
Aline Martin et al.
ENDOCRINOLOGY (2008)
Osteocyte-derived sclerostin inhibits bone formation:: Its role in bone morphogenetic protein and Wnt signaling
Peter ten Dijke et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2008)
MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: An inhibition regulated by PHEX cleavage of ASARM
William N. Addison et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Matrix mineralization as a trigger for osteocyte maturation
Kazuharu Irie et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)
Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin
Alexander G. Robling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Dentin matrix protein 1 (DMP1): New and important roles for biomineralization and phosphate homeostasis
C. Qin et al.
JOURNAL OF DENTAL RESEARCH (2007)
Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone
G. Silvestrini et al.
JOURNAL OF MOLECULAR HISTOLOGY (2007)
Update in osteoporosis and metabolic bone disorders
Dolores Shoback
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation
Rutger L. van Bezooijen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Mechanism by which MLO-A5 late osteoblasts/early osteocytes mineralize in culture: Similarities with mineralization of lamellar bone
C. Barragan-Adjemian et al.
CALCIFIED TISSUE INTERNATIONAL (2006)
Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism
Jian Q. Feng et al.
NATURE GENETICS (2006)
Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin
Peter S. N. Rowe et al.
BONE (2006)
Pathogenic role of Fgf23 in Hyp mice
Shiguang Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
E11/gp38 selective expression in osteocytes: Regulation by mechanical strain and role in dendrite elongation
Keqin Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Regulation of bone mass by Wnt signaling
V Krishnan et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis
T Bellido et al.
ENDOCRINOLOGY (2005)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins
DG Winkler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP)
PSN Rowe et al.
BONE (2005)
The proliferation and phenotypic expression of human osteoblasts on tantalum metal
DM Findlay et al.
BIOMATERIALS (2004)
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
RL van Bezooijen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
MEPE has the properties of an osteoblastic phosphatonin and minhibin
PSN Rowe et al.
BONE (2004)
The wrickkened pathways of FGF23, MEPE and PHEX
PSN Rowe
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE (2004)
Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts
MK Sutherland et al.
BONE (2004)
Spaciotemporal association and bone morphogenetic protein regulation of Sclerostin and Osterix expression during embryonic osteogenesis
Y Ohyama et al.
ENDOCRINOLOGY (2004)
Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity
N Kusu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
RANKL expression is related to the differentiation state of human osteoblasts
GJ Atkins et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family
JW Goding et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2003)
Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass
LC Gowen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
Y Yamazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Inhibition of MEPE cleavage by Phex
R Guo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population
K Staehling-Hampton et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
W Balemans et al.
JOURNAL OF MEDICAL GENETICS (2002)
MEPE, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone
L Argiro et al.
GENOMICS (2001)
Role of the mouse ank gene in control of tissue calcification and arthritis
AM Ho et al.
SCIENCE (2000)
分享论文
